Acumen Pharmaceuticals Inc

ABOS NASDAQ Santé & Biotech États-Unis US00509G2093
2.15 $
6.11 %

Société biopharmaceutique en phase clinique, centrée sur le développement de traitements pour les maladies neurodégénératives telles que la maladie d'Alzheimer.

Performance & Momentum

6 Months 10.82 %
1 Year 79.17 %
3 Years 58.65 %
5 Years 89.40 %

Similar stocks to Acumen Pharmaceuticals Inc

Anantys Community

Be the first to share your analysis on Acumen Pharmaceuticals Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases